Company / Shareholders' Equity
Schrödinger, Inc. Shareholders' Equity History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$364.1M
FY2025
5-year range
$364.1M / $557.1M
FY2021-FY2025
Trend
-13.6%
vs FY2024
Sector context
#119 of 161
Health Care
What the data says
At $364M, Schrödinger, Inc.'s shareholders' equity ranks #119 of 161 in the Health Care sector. Shareholders' Equity has declined for 3 consecutive years, from $557M in FY2022 to $364M in FY2025.
Based on SEC 10-K filings.
$364M in FY2025 with a 5-year CAGR of -10.2%.
Declined from $549M to $364M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -13.2%
- 5-Year CAGR
- -10.2%
- 10-Year CAGR
- -
Sector benchmark
#119 of 161 in Health CareTop 74% of 161This company $364.1M Sector average $5.1B
▼
-92.8% below sector average
Key checks
Key Insights
- Schrödinger, Inc.'s shareholders' equity has declined for 3 consecutive years.
- 5-year CAGR of -10.2%, indicating a declining trend.
- In FY2025, shareholders' equity decreased 13.6% year-over-year.
- Ranks #119 out of 161 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $364.1M | -13.6% |
| FY2024 | $421.4M | -23.2% |
| FY2023 | $548.6M | -1.5% |
| FY2022 | $557.1M | +0.0% |
| FY2021 | $557.1M | -10.7% |
| FY2020 | $624.0M | +768.7% |
| FY2019 | -$93.3M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026